Related references
Note: Only part of the references are listed.Oral Azole Antifungal Medications and Risk of Acute Liver Injury, Overall and by Chronic Liver Disease Status
Vincent Lo Re et al.
AMERICAN JOURNAL OF MEDICINE (2016)
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
Thomas F. Patterson et al.
CLINICAL INFECTIOUS DISEASES (2016)
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial
Johan A. Maertens et al.
LANCET (2016)
Clinical evidence for caspofungin monotherapy in the first-line and salvage therapy of invasive Aspergillus infections
Werner J. Heinz et al.
MYCOSES (2016)
Influence of mould-active antifungal treatment on the performance of the Aspergillus-specific bronchoalveolar lavage fluid lateral-flow device test
Susanne Eigl et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2015)
Multicenter evaluation of a lateral-flow device test for diagnosing invasive pulmonary aspergillosis in ICU patients
Susanne Eigl et al.
CRITICAL CARE (2015)
Novel Tests for Diagnosis of Invasive Aspergillosis in Patients with Underlying Respiratory Diseases
Juergen Prattes et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Serum Galactomannan-Based Early Detection of Invasive Aspergillosis in Hematology Patients Receiving Effective Antimold Prophylaxis
Rafael F. Duarte et al.
CLINICAL INFECTIOUS DISEASES (2014)
Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance
Agustin Albillos et al.
JOURNAL OF HEPATOLOGY (2014)
Invasive aspergillosis in patients with severe alcoholic hepatitis
Thierry Gustot et al.
JOURNAL OF HEPATOLOGY (2014)
Bronchoalveolar Lavage Lateral-Flow Device Test for Invasive Pulmonary Aspergillosis in Solid Organ Transplant Patients: A Semiprospective Multicenter Study
Birgit Willinger et al.
TRANSPLANTATION (2014)
Potential Factors for Inadequate Voriconazole Plasma Concentrations in Intensive Care Unit Patients and Patients with Hematological Malignancies
Martin Hoenigl et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Invasive pulmonary aspergillosis in non-neutropenic patients with and without underlying disease: A single-centre retrospective analysis of 52 subjects
Zhichu Dai et al.
RESPIROLOGY (2013)
INVASIVE ASPERGILLOSIS IN PATIENTS WITH CIRRHOSIS, A CASE REPORT AND REVIEW OF THE LAST 10 YEARS
S. Jeurissen et al.
ACTA CLINICA BELGICA (2013)
The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies
Anne Bergeron et al.
BLOOD (2012)
European Organization for the Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) host factors and invasive fungal infections in patients with haematological malignancies
Martin Hoenigl et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Immune Dysfunction and Infections in Patients With Cirrhosis
Alexander R. Bonnel et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Triazole antifungal agents drug-drug interactions involving hepatic cytochrome P450
Paul O. Gubbins
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2011)
Invasive Pulmonary Aspergillosis in Non-Neutropenic Patients: Analysis of a 14-Month Prospective Clinical Experience
A. Russo et al.
JOURNAL OF CHEMOTHERAPY (2011)
Invasive aspergillosis in patients with liver disease
Marco Falcone et al.
MEDICAL MYCOLOGY (2011)
Correlation between galactomannan antigen levels in serum and neutrophil counts in haematological patients with invasive aspergillosis
C. Cordonnier et al.
CLINICAL MICROBIOLOGY AND INFECTION (2009)
MEDICAL PROGRESS Aspergillosis
Brahm H. Segal
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
Ben De Pauw et al.
CLINICAL INFECTIOUS DISEASES (2008)
Human platelets attenuate Aspergillus species via granule-dependent mechanisms
Susanne Perkhofer et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Non-decompensated cirrhosis as a risk factor for invasive aspergillosis: A case report and review of the immune dysfunction of cirrhosis
Anne B. Lipke et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2007)
Invasive pulmonary aspergillosis in patients with decompensated cirrhosis: case series
Helene Prodanovic et al.
BMC GASTROENTEROLOGY (2007)
Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients:: A 6-year survey
A. Cornillet et al.
CLINICAL INFECTIOUS DISEASES (2006)
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies
G D'Amico et al.
JOURNAL OF HEPATOLOGY (2006)
Initial CT manifestations of invasive pulmonary aspergillosis in 45 non-HIV immunocompromised patients: association with patient outcome?
M Horger et al.
EUROPEAN JOURNAL OF RADIOLOGY (2005)
Invasive aspergillosis in critically ill patients without malignancy
W Meersseman et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Invasive aspergillosis in critically ill patients: Analysis of risk factors for acquisition and mortality
K Vandewoude et al.
ACTA CLINICA BELGICA (2004)
Glucocorticoids and invasive fungal infections
MS Lionakis et al.
LANCET (2003)
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis
R Herbrecht et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
In vivo neutrophil dysfunction in cirrhotic patients with advanced liver disease
C Fiuza et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Share Paper
